| JYHB1800328 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2018-03-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-06-12 | view |
| JYHZ2100521 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | License Renew | 2021-04-19 | | | | | view |
| JXHL1700009 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2017-02-06 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2017-06-27 | view |
| CYHS2301517 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2023-06-03 | | Hunan Jiudian Pharmaceutical Co Ltd | | | view |
| JYHB2100083 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2021-01-21 | 阿斯利康制药有限公司 | Astrazeneca Pharmaceutical Co Ltd | Filed | 2021-01-28 | view |
| CYHS2300929 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2023-03-30 | | Shijiazhuang NO4 Pharmaceutical Co Ltd | | | view |
| JYHB1900717 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2019-06-22 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2019-09-16 | view |
| CYHS2402364 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2024-07-26 | | Hinye Pharmaceutical Co Ltd | | | view |
| CXHL1401109 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2014-09-12 | 安徽联创药物化学有限公司 | Anhui Lianchuang Biological Medicine Co Ltd | Certificate Issued | 2016-03-17 | view |
| JYHB2101224 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2021-07-01 | | | | | view |
| JYHB1700960 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-07-19 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2018-11-09 | view |
| CYHS2302512 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2023-09-19 | | Front Pharmaceutical PLC | | | view |
| CYHS2102254 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-12-23 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
| CXHL1501501 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-08-24 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2016-08-23 | view |
| JXHS2000028 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(2.4) | Import Drug Application | 2020-03-18 | 阿斯利康投资（中国）有限公司 | Astrazeneca Investment (China) Co Ltd | Certificate Issued | 2021-02-03 | view |
| CYHS2403227 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2024-09-25 | | | | | view |
| JYHB2101314 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2021-08-12 | | | | | view |
| CXHL1401775 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(3.1) | New Drug Application | 2015-02-10 | 南京卡文迪许生物工程技术有限公司 | Nanjing Cavendish Bio-engineering Technology Co Ltd | Certificate Issued | 2016-05-19 | view |
| CYHS2102255 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs(4) | Generic Drug | 2021-12-23 | | Nanjing Zhengda Tianqing Pharmaceutical Co Ltd | | | view |
| JXHL0800426 | 达格列净片 | dapagliflozin | Tablet | Chemical Drugs | Import Drug Application | 2008-12-18 | 百时美施贵宝(中国)投资有限公司 | BRISTOL-MYERS Squibb (CHINA) Co Ltd | Certificate Issued | 2010-04-16 | view |
